Colleen Sweeney

InstitutionUniversity of California Davis
AddressResearch III/UCDMC
CA 95817
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Hatakeyama J, Wald JH, Rafidi H, Cuevas A, Sweeney C, Carraway KL. The ER structural protein Rtn4A stabilizes and enhances signaling through the receptor tyrosine kinase ErbB3. Sci Signal. 2016 06 28; 9(434):ra65. PMID: 27353365.
      View in: PubMed
    2. Amir S, Simion C, Umeh-Garcia M, Krig S, Moss T, Carraway KL, Sweeney C. Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer. Br J Cancer. 2016 05 10; 114(10):1125-34. PMID: 27100732.
      View in: PubMed
    3. Rowson-Hodel AR, Berg AL, Wald JH, Hatakeyama J, VanderVorst K, Curiel DA, Leon LJ, Sweeney C, Carraway KL. Hexamethylene amiloride engages a novel reactive oxygen species- and lysosome-dependent programmed necrotic mechanism to selectively target breast cancer cells. Cancer Lett. 2016 May 28; 375(1):62-72. PMID: 26944316.
      View in: PubMed
    4. Bekki K, Vogel H, Li W, Ito T, Sweeney C, Haarmann-Stemmann T, Matsumura F, Vogel CF. The aryl hydrocarbon receptor (AhR) mediates resistance to apoptosis induced in breast cancer cells. Pestic Biochem Physiol. 2015 May; 120:5-13. PMID: 25987214; PMCID: PMC4438266.
    5. Simion C, Cedano-Prieto ME, Sweeney C. The LRIG family: enigmatic regulators of growth factor receptor signaling. Endocr Relat Cancer. 2014; 21(6):R431-43. PMID: 25183430; PMCID: PMC4182143.
    6. Printsev I, Yen L, Sweeney C, Carraway KL. Oligomerization of the Nrdp1 E3 ubiquitin ligase is necessary for efficient autoubiquitination but not ErbB3 ubiquitination. J Biol Chem. 2014 Mar 21; 289(12):8570-8. PMID: 24519943; PMCID: PMC3961680.
    7. Rafidi H, Mercado F, Astudillo M, Fry WH, Saldana M, Carraway KL, Sweeney C. Leucine-rich repeat and immunoglobulin domain-containing protein-1 (Lrig1) negative regulatory action toward ErbB receptor tyrosine kinases is opposed by leucine-rich repeat and immunoglobulin domain-containing protein 3 (Lrig3). J Biol Chem. 2013 Jul 26; 288(30):21593-605. PMID: 23723069; PMCID: PMC3724619.
    8. Krig SR, Frietze S, Simion C, Miller JK, Fry WH, Rafidi H, Kotelawala L, Qi L, Griffith OL, Gray JW, Carraway KL, Sweeney C. Lrig1 is an estrogen-regulated growth suppressor and correlates with longer relapse-free survival in ERa-positive breast cancer. Mol Cancer Res. 2011 Oct; 9(10):1406-17. PMID: 21821674; PMCID: PMC3196675.
    9. Vogel CF, Li W, Wu D, Miller JK, Sweeney C, Lazennec G, Fujisawa Y, Matsumura F. Interaction of aryl hydrocarbon receptor and NF-?B subunit RelB in breast cancer is associated with interleukin-8 overexpression. Arch Biochem Biophys. 2011 Aug 01; 512(1):78-86. PMID: 21640702; PMCID: PMC3135412.
    10. Fry WH, Simion C, Sweeney C, Carraway KL. Quantity control of the ErbB3 receptor tyrosine kinase at the endoplasmic reticulum. Mol Cell Biol. 2011 Jul; 31(14):3009-18. PMID: 21576364; PMCID: PMC3133396.
    11. Ingalla EQ, Miller JK, Wald JH, Workman HC, Kaur RP, Yen L, Fry WH, Borowsky AD, Young LJ, Sweeney C, Carraway KL. Post-transcriptional mechanisms contribute to the suppression of the ErbB3 negative regulator protein Nrdp1 in mammary tumors. J Biol Chem. 2010 Sep 10; 285(37):28691-7. PMID: 20628057; PMCID: PMC2937896.
    12. Khan IH, Zhao J, Ghosh P, Ziman M, Sweeney C, Kung HJ, Luciw PA. Microbead arrays for the analysis of ErbB receptor tyrosine kinase activation and dimerization in breast cancer cells. Assay Drug Dev Technol. 2010 Feb; 8(1):27-36. PMID: 20035613; PMCID: PMC3196214.
    13. Workman HC, Sweeney C, Carraway KL. The membrane mucin Muc4 inhibits apoptosis induced by multiple insults via ErbB2-dependent and ErbB2-independent mechanisms. Cancer Res. 2009 Apr 01; 69(7):2845-52. PMID: 19293191; PMCID: PMC2745945.
    14. Workman HC, Miller JK, Ingalla EQ, Kaur RP, Yamamoto DI, Beckett LA, Young LJ, Cardiff RD, Borowsky AD, Carraway KL, Sweeney C, Carraway KL. The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cells. Breast Cancer Res. 2009; 11(5):R70. PMID: 19761616; PMCID: PMC2790847.
    15. Miller JK, Shattuck DL, Ingalla EQ, Yen L, Borowsky AD, Young LJ, Cardiff RD, Carraway KL, Sweeney C. Suppression of the negative regulator LRIG1 contributes to ErbB2 overexpression in breast cancer. Cancer Res. 2008 Oct 15; 68(20):8286-94. PMID: 18922900; PMCID: PMC2597648.
    16. Fry WH, Kotelawala L, Sweeney C, Carraway KL. Mechanisms of ErbB receptor negative regulation and relevance in cancer. Exp Cell Res. 2009 Feb 15; 315(4):697-706. PMID: 18706412; PMCID: PMC2667444.
    17. Shattuck DL, Miller JK, Carraway KL, Sweeney C. Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells. Cancer Res. 2008 Mar 01; 68(5):1471-7. PMID: 18316611.
      View in: PubMed
    18. Cao Z, Wu X, Yen L, Sweeney C, Carraway KL. Neuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1. Mol Cell Biol. 2007 Mar; 27(6):2180-8. PMID: 17210635; PMCID: PMC1820496.
    19. Carraway KL, Funes M, Workman HC, Sweeney C. Contribution of membrane mucins to tumor progression through modulation of cellular growth signaling pathways. Curr Top Dev Biol. 2007; 78:1-22. PMID: 17338913.
      View in: PubMed
    20. Shattuck DL, Miller JK, Laederich M, Funes M, Petersen H, Carraway KL, Sweeney C. LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy. Mol Cell Biol. 2007 Mar; 27(5):1934-46. PMID: 17178829; PMCID: PMC1820466.
    21. Yen L, Cao Z, Wu X, Ingalla ER, Baron C, Young LJ, Gregg JP, Cardiff RD, Borowsky AD, Sweeney C, Carraway KL. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth. Cancer Res. 2006 Dec 01; 66(23):11279-86. PMID: 17145873.
      View in: PubMed
    22. Carraway KL, Sweeney C. Co-opted integrin signaling in ErbB2-induced mammary tumor progression. Cancer Cell. 2006 Aug; 10(2):93-5. PMID: 16904607.
      View in: PubMed
    23. Funes M, Miller JK, Lai C, Carraway KL, Sweeney C. The mucin Muc4 potentiates neuregulin signaling by increasing the cell-surface populations of ErbB2 and ErbB3. J Biol Chem. 2006 Jul 14; 281(28):19310-9. PMID: 16690615.
      View in: PubMed
    24. Sweeney C, Miller JK, Shattuck DL, Carraway KL. ErbB receptor negative regulatory mechanisms: implications in cancer. J Mammary Gland Biol Neoplasia. 2006 Jan; 11(1):89-99. PMID: 16865534.
      View in: PubMed
    25. Wu X, Yen L, Irwin L, Sweeney C, Carraway KL. Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8. Mol Cell Biol. 2004 Sep; 24(17):7748-57. PMID: 15314180; PMCID: PMC506982.
    26. Laederich MB, Funes-Duran M, Yen L, Ingalla E, Wu X, Carraway KL, Sweeney C. The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases. J Biol Chem. 2004 Nov 05; 279(45):47050-6. PMID: 15345710.
      View in: PubMed
    27. Sweeney C, Carraway KL. Negative regulation of ErbB family receptor tyrosine kinases. Br J Cancer. 2004 Jan 26; 90(2):289-93. PMID: 14735165; PMCID: PMC2409562.
    28. Ravid T, Sweeney C, Gee P, Carraway KL, Goldkorn T. Epidermal growth factor receptor activation under oxidative stress fails to promote c-Cbl mediated down-regulation. J Biol Chem. 2002 Aug 23; 277(34):31214-9. PMID: 12063263.
      View in: PubMed
    29. Carraway KL, Sweeney C. EGF receptor activation by heterologous mechanisms. Cancer Cell. 2002 Jun; 1(5):405-6. PMID: 12124166.
      View in: PubMed
    30. Diamonti AJ, Guy PM, Ivanof C, Wong K, Sweeney C, Carraway KL. An RBCC protein implicated in maintenance of steady-state neuregulin receptor levels. Proc Natl Acad Sci U S A. 2002 Mar 05; 99(5):2866-71. PMID: 11867753; PMCID: PMC122439.
    31. Sweeney C, Fambrough D, Huard C, Diamonti AJ, Lander ES, Cantley LC, Carraway KL. Growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors. J Biol Chem. 2001 Jun 22; 276(25):22685-98. PMID: 11297548.
      View in: PubMed